Heidi Cuthbert

Cyprium Metals (ASX:CYM) has initiated acid solution commissioning on existing heap leach pads at the Nifty Copper Complex.

Amgen (NASDAQ:AMGN) received U.S. FDA approval to update the prescribing information for IMDELLTRA, reducing the initial monitoring time to 6–8 hours.

Definium Therapeutics (NASDAQ:DFTX) reported positive topline results from the Phase 3 Panorama study evaluating DT120 (lysergide) Orally Disintegrating Tablet in adults with generalized anxiety disorder.

Hain Celestial (NASDAQ:HAIN) agreed to sell the majority of its International business to private equity firm AURELIUS for approximately $323 million in cash as part of its strategic transformation plan.

The Elmet Group (NASDAQ:ELMT) plans to deploy a committed $450 million U.S. Department of War investment to develop a more vertically integrated tungsten supply chain.

Johnson & Johnson (NYSE:JNJ) reported final Phase 3 PAPILLON results showing median overall survival of 34.3 months with first-line IV RYBREVANT plus carboplatin-pemetrexed versus 27.9 months with chemotherapy alone.

Exploration company Albion Resources (ASX:ALB) has commenced a maiden 7,000-metre drilling programme at its Gidgee Gold Project.

Connected Minerals (ASX:CML) has commenced a 6,000m drilling programme at its Bailundo Carbonatite Project in Angola.

Prominence Energy (ASX:PRM) completed an independent review of helium prospective resources at its Eyre Project.

Wide Open Agriculture (ASX:WOA) signed three additional non-binding framework agreements with manufacturers in Vietnam, India, and Indonesia.